Late-breaking Trials III

In this PVI Course 2024 session dedicated to late-breaking trials, discover key findings from the CLOUT OUT and eSEPARATE studies, which leverage machine learning and impedance analysis to better understand thrombus characteristics in PAD, and the SEPARATE study on in-vivo clot composition. Uncover the potential of digital twin technology for carotid stenting in the CASSIS 1 and 2 studies, examine insights from a nationwide analysis of AV access thrombosis and survival, and review the 2-year results of the LUMIFOLLOW Registry on therapies for SFA and popliteal arteries.

Don’t miss this deep dive into cutting-edge research!